Indeed Snapshot

Track Dicerna Pharmaceuticals reviews on Indeed to uncover insights on employee sentiment
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Company Name Sector Industry
nasdaq:drna https://www.indeed.com/cmp/dicerna-pharmaceuticals Aug 29th, 2022 12:00AM Open Dicerna Pharmaceuticals Pharmaceutical & Biotechnology At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives. RRv1_25M_100M 33 Hayden Ave, Lexington MA 02421 Douglas M. Fambrough, Ph.D. 2.70 3.00 3.00 2.00 3.00 2.30 1.70 2.70 Aug 29th, 2022 11:53AM Aug 29th, 2022 11:53AM Dicerna Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:drna https://www.indeed.com/cmp/dicerna-pharmaceuticals Aug 28th, 2022 12:00AM Open Dicerna Pharmaceuticals Pharmaceutical & Biotechnology At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives. RRv1_25M_100M 33 Hayden Ave, Lexington MA 02421 Douglas M. Fambrough, Ph.D. 2.70 3.00 3.00 2.00 3.00 2.30 1.70 2.70 Aug 28th, 2022 04:52AM Aug 28th, 2022 04:52AM Dicerna Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:drna https://www.indeed.com/cmp/dicerna-pharmaceuticals Aug 27th, 2022 12:00AM Open Dicerna Pharmaceuticals Pharmaceutical & Biotechnology At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives. RRv1_25M_100M 33 Hayden Ave, Lexington MA 02421 Douglas M. Fambrough, Ph.D. 2.70 3.00 3.00 2.00 3.00 2.30 1.70 2.70 Aug 27th, 2022 04:11AM Aug 27th, 2022 04:11AM Dicerna Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:drna https://www.indeed.com/cmp/dicerna-pharmaceuticals Aug 25th, 2022 12:00AM Open Dicerna Pharmaceuticals Pharmaceutical & Biotechnology At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives. RRv1_25M_100M 33 Hayden Ave, Lexington MA 02421 Douglas M. Fambrough, Ph.D. 2.70 3.00 3.00 2.00 3.00 2.30 1.70 2.70 Aug 25th, 2022 08:51AM Aug 25th, 2022 08:51AM Dicerna Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:drna https://www.indeed.com/cmp/dicerna-pharmaceuticals Aug 23rd, 2022 12:00AM Open Dicerna Pharmaceuticals Pharmaceutical & Biotechnology At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives. RRv1_25M_100M 33 Hayden Ave, Lexington MA 02421 Douglas M. Fambrough, Ph.D. 2.70 3.00 3.00 2.00 3.00 2.30 1.70 2.70 Aug 23rd, 2022 10:44AM Aug 23rd, 2022 10:44AM Dicerna Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:drna https://www.indeed.com/cmp/dicerna-pharmaceuticals Aug 21st, 2022 12:00AM Open Dicerna Pharmaceuticals Pharmaceutical & Biotechnology At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives. RRv1_25M_100M 33 Hayden Ave, Lexington MA 02421 Douglas M. Fambrough, Ph.D. 2.70 3.00 3.00 2.00 3.00 2.30 1.70 2.70 Aug 21st, 2022 12:28PM Aug 21st, 2022 12:28PM Dicerna Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:drna https://www.indeed.com/cmp/dicerna-pharmaceuticals Aug 20th, 2022 12:00AM Open Dicerna Pharmaceuticals Pharmaceutical & Biotechnology At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives. RRv1_25M_100M 33 Hayden Ave, Lexington MA 02421 Douglas M. Fambrough, Ph.D. 2.70 3.00 3.00 2.00 3.00 2.30 1.70 2.70 Aug 20th, 2022 02:05PM Aug 20th, 2022 02:05PM Dicerna Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:drna https://www.indeed.com/cmp/dicerna-pharmaceuticals Aug 19th, 2022 12:00AM Open Dicerna Pharmaceuticals Pharmaceutical & Biotechnology At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives. RRv1_25M_100M 33 Hayden Ave, Lexington MA 02421 Douglas M. Fambrough, Ph.D. 2.70 3.00 3.00 2.00 3.00 2.30 1.70 2.70 Aug 19th, 2022 12:28PM Aug 19th, 2022 12:28PM Dicerna Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:drna https://www.indeed.com/cmp/dicerna-pharmaceuticals Aug 18th, 2022 12:00AM Open Dicerna Pharmaceuticals Pharmaceutical & Biotechnology At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives. RRv1_25M_100M 33 Hayden Ave, Lexington MA 02421 Douglas M. Fambrough, Ph.D. 2.70 3.00 3.00 2.00 3.00 2.30 1.70 2.70 Aug 18th, 2022 04:12AM Aug 18th, 2022 04:12AM Dicerna Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:drna https://www.indeed.com/cmp/dicerna-pharmaceuticals Aug 17th, 2022 12:00AM Open Dicerna Pharmaceuticals Pharmaceutical & Biotechnology At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives. RRv1_25M_100M 33 Hayden Ave, Lexington MA 02421 Douglas M. Fambrough, Ph.D. 2.70 3.00 3.00 2.00 3.00 2.30 1.70 2.70 Aug 17th, 2022 09:51AM Aug 17th, 2022 09:51AM Dicerna Pharmaceuticals Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.